newsfilter
← Latest News
GlobeNewswire·

ProMIS Neurosciences to Participate in H.C. Wainwright & Co. 23rd Annual Investment Conference

TORONTO and CAMBRIDGE, Mass., Sept. 13, 2021 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX:PMN) (OTCQB:ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the d